Peregrine Pharmaceuticals (NASDAQ:PPHM) on Mar. 13 announced that preclinical data presented at two Keystone Symposia support the immune-stimulatory mechanism of action and therapeutic potential of the company’s phosphatidylserine (PS)-targeting antibodies in both oncology and antiviral therapeutic areas. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock opened at $2.40 in last session, and closed at $2.23, while the day range of Peregrine Pharmaceuticals (NASDAQ:PPHM) stock is $2.21 – $2.41. The stock showed a positive weekly performance of -14.56%.
Global Sources Ltd. Bermuda (NASDAQ:GSOL) generates its revenue from proving integrated marketing services and information, mainly to the China market. Having just released earnings and announced shares tendering, the stock can be seen going skyward. As of 10:40 a.m. Global Sources Ltd. (Bermuda) (NASDAQ:GSOL) stock opened at $8.02 in last session, and closed at $8.07 by gaining 19.38%. The 52 week range of $5.55 – $8.42. Company’s market capitalization is $278.05 million.
On March 13, 2014, Venaxis, Inc. (NASDAQ:APPY) issued a press release titled – “Venaxis Announces Positive Top-Line Results from Pivotal Study of APPY1 Test.” Venaxis Inc. (NASDAQ:APPY) stock increased 21.36% and finished the last session at $3.29. The EPS of the stock remained -0.93. Company’s market capitalization is $70.58 million.
B. Riley began coverage on shares of Jive Software (NASDAQ:JIVE) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $17.00 price target on the stock. Jive Software Inc. (NASDAQ:JIVE) stock opened the session at $9.36, and closed the session at $8.92. The 52 week range of the Jive Software Inc. (NASDAQ:JIVE) stock remained $7.11 – $18.48 and the day range was $8.87 – $9.39.
Leave a Reply